Caris Life Sciences, Inc.
CAI
Hisse Senetlerindeki Sıralama
#2189
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Hisse Fiyatı
$32.28
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$9.12B
Değişim (1 gün)
3.76%
Değişim (1 yıl)
7.46%
Ülke
US
Ticaret Caris Life Sciences, Inc. (CAI)
Kategori
Healthcare
Caris Life Sciences, Inc. (CAI) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $29.65 - 2026-10-01
Gün sonu en düşük fiyat: $26.95 - 2025-06-01
Gün sonu en düşük fiyat: $26.95 - 2025-06-01
Caris Life Sciences, Inc. için hisse fiyatı geçmişi: 2025 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | -17.75% |
| 2025 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
